id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
SSA-2006-0149-0239,SSA,SSA-2006-0149,Medical Criteria for Evaluating Respiratory System Disorders,Rule,,2016-09-19T04:00:00Z,2016,9,2016-09-19T04:00:00Z,,2016-09-19T11:55:01Z,C1-2016-13275,0,0,0900006482225ce9
SSA-2006-0149-0238,SSA,SSA-2006-0149,Revised Medical Criteria for Evaluating Respiratory System Disorders,Rule,,2016-06-09T04:00:00Z,2016,6,2016-06-09T04:00:00Z,,2016-06-10T18:23:57Z,2016-13275,0,0,0900006482025b49
SSA-2006-0149-0237,SSA,SSA-2006-0149,Teleconference on Proposed Medical Criteria for Evaluating Cystic Fibrosis,Supporting & Related Material,,2013-05-17T04:00:00Z,2013,5,,,2013-05-17T17:53:36Z,,0,0,09000064812ea705
SSA-2006-0149-0236,SSA,SSA-2006-0149,Medical Criteria for Evaluating Cystic Fibrosis,Notice,,2013-05-07T04:00:00Z,2013,5,2013-05-07T04:00:00Z,,2013-05-07T17:26:21Z,2013-10702,0,0,09000064812bd9d9
SSA-2006-0149-0024,SSA,SSA-2006-0149,Revised Medical Criteria for Evaluating Respiratory System Disorders,Proposed Rule,,2013-02-04T05:00:00Z,2013,2,2013-02-04T05:00:00Z,2013-04-06T03:59:59Z,2016-09-19T11:50:46Z,2013-02165,0,0,09000064811e4e0c